Abstract:Key PointsNitric oxide (NO) is a gaseous signalling molecule that is involved in the regulation of the cardiovascular, immune and nervous systems.In the CNS, NO is involved in many processes, including the regulation of synaptic plasticity, the sleep–wake cycle, neurosecretion, fluid balance and reproductive processes. In the PNS, NO is an inhibitory neurotransmitter that mediates the non-adrenergic, non-cholinergic relaxation of smooth muscle in both the gastrointestinal and urogenital tracts.NO exerts its effect on an array of functions through the activation of several intracellular signalling pathways. One key pathway is the soluble guanylyl cyclase–cyclic GMP–protein kinase G system.Physiological amounts of NO are neuroprotective, owing to S-nitrosylation of NMDA (N-methyl-D-aspartate) receptor subunits or of the active sites of caspases. Furthermore, NO activates Akt and CREB (cyclic AMP-responsive-element-binding protein), which are involved in two important survival pathways. NO also induces haem oxygenase 1, a key enzyme in the cellular stress response.If it is produced in excess, or if a cell is under conditions of oxidative stress, NO becomes noxious and may undergo an oxidative–reductive reaction to form toxic compounds known as reactive nitrogen species (RNS), which cause cell damage. Both NO and RNS have a pathogenetic role in the onset and development of neurodegenerative disorders.Although drugs that act on the NO–cGMP pathway are commonly used to treat impotence, lung diseases and pulmonary hypertension, their use for the prevention of neurodegenerative disorders is unlikely. The use of natural antioxidants, such as polyphenols, has been proposed for the prevention or treatment of Alzheimer's disease because of their in vitro ability to counteract NO-induced damage. However, the pharmacokinetics of these substances may limit their use in humans, and so more effort would be required to make these natural substances efficient in the treatment of neurodegenerative disorders.

Nitric oxide synthase in hypoxic or ischemic brain injury.

Inducible Nitric Oxide Synthase and Brain Hypoxic-Ischemic Brain Damage

Roles of Nitric Oxide in Brain Ischemia and Reperfusion

Roles of Nitric Oxide Synthase Isoforms in Neurogenesis

Pathophysiology and Therapeutic Potential of NADPH Oxidases in Ischemic Stroke-Induced Oxidative Stress.

Dynamics of Nitric Oxide and Peroxynitrite During Global Brain Ischemia/Reperfusion in Rat Hippocampus: NO-sensor Measurement and Modeling Study

Targeting Nitrosative Stress as a Therapeutic Strategy for Neurovascular Protection in Brain Ischemia

Oxidative Stress And Nitric Oxide In Cerebral Ischemic Reperfusion Injury

The dynamic detection of NO during stroke and reperfusion in vivo.

Modeling the Diffusion of Nitric Oxide Produced by Neuronal Cells in Brain Ischemia

The Dual Role of Inducible Nitric Oxide Synthase in Myocardial Ischemia/Reperfusion Injury: Friend or Foe?

Dynamics of Nitric Oxide Concentration Changes During Global Brain Ischemia/Reperfusion in Rat Hippocampus

Study Progress of Nitric Oxide about Its Mechanism in Brain Injury During Extracorporeal Circulation

Targeting nitrosative stress for neurovascular protection: new implications in brain diseases.

Reduced Neuronal Nitric Oxide Synthase is Involved in Ischemia‐induced Hippocampal Neurogenesis by Up‐regulating Inducible Nitric Oxide Synthase Expression

[Progress in the Studies on Neuronal Nitric Oxide Synthase Inhibitors].

Real-time measurement of murine hippocampus NO levels in response to cerebral ischemia/reperfusion.

Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity

The Role Of Nitric Oxide In Stroke

Time Course of Expression of Three Nitric Oxide Synthase Isoforms After Transient Middle Cerebral Artery Occlusion in Rats.

Endothelial nitric oxide synthase protects neurons against ischemic injury through regulation of brain-derived neurotrophic factor expression.